X

Illumina, Inc (ILMN) Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

Newsdesk: